No definition available.
Phakomatoses, not elsewhere classified
EFO MESH Endpoint Browser PheWeb
Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
420 |
4. Check minimum number of eventsNone |
420 |
5. Include endpointsNone |
420 |
6. Filter based on genotype QC (FinnGen only) |
420 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q8
- Name in latin
- Phacomatoses non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Phakomatoses, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3534 | 1781 | 1742 |
| Only index persons | 2959 | 1519 | 1440 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.05 |
| Only index persons | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 24.21 | 27.82 | 20.38 |
| Only index persons | 27.09 | 30.36 | 23.64 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 420 | 241 | 179 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.08 |
| Median age at first event (years) | 36.12 | 36.50 | 35.61 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 373
- Matched controls
- 3730
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
+∞
255.7
215
*
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
2303.8
159.4
143
*
Z31.5
ICD-10 Finland
Genetic counselling
20.4
95.0
151
120
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
90.4
83
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
+∞
75.6
70
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
65.6
61
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
10.9
56.6
118
152
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
+∞
52.3
49
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.6
40.0
138
352
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
9.9
36.5
77
95
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.5
34.2
74
95
74340
ICD-8 Finland
Other congenital anomalies of nervous system, Neurofibromatosis
+∞
33.9
32
*
Q85.9
ICD-10 Finland
Phakomatosis, unspecified
+∞
31.7
30
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.5
24.4
60
93
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
24.2
23
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
11.7
23.0
43
41
D33.30
ICD-10 Finland
Acoustic neuroma
43.1
23.0
28
7
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
13.2
19.5
34
28
XCK00
NOMESCO Finland
Perimetry
7.1
19.5
49
78
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
26.7
18.5
25
10
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
55.4
18.1
21
*
N03AF02
ATC
oxcarbazepine; oral
9.8
17.3
35
39
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
17.3
163
832
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.9
17.3
40
56
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
14.3
16.8
28
21
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
19.0
16.7
25
14
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
15.5
167
902
ZXC10
NOMESCO Finland
Use of laser
12.6
15.3
27
23
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.5
14.8
55
139
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
83.5
14.7
16
*
Q82.50
ICD-10 Finland
Naevus flammeus
+∞
14.7
14
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
14.2
14.4
24
18
WX402
NOMESCO Finland
General anaesthesia
3.0
13.9
91
362
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.7
13.9
32
45
XA800
NOMESCO Finland
Neuropsychological investigation
5.4
13.8
42
86
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
10.7
13.7
26
26
Q85.80
ICD-10 Finland
Peutz-Jegher syndrome
+∞
13.6
13
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
9.1
13.5
28
33
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
13.1
127
636
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
13.1
108
494
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
72.4
12.7
14
*
WX002
NOMESCO Finland
Sedation and analgesia
2.9
12.4
84
340
183
Kela drug reimbursment
Lamotrigin and topiramate
13.0
12.3
21
17
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.4
11.9
24
27
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
11.8
69
252
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
13.1
11.8
20
16
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
14.2
11.6
19
14
Q85.83
ICD-10 Finland
Gardner syndrome
+∞
11.5
11
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
12.4
11.5
20
17
ZXC07
NOMESCO Finland
Carbon dioxide laser
36.2
11.3
14
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.7
11.2
51
155
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
44.7
11.0
13
*
N03AG04
ATC
vigabatrin; oral
44.7
11.0
13
*
181
Kela drug reimbursment
Retigabine and vigabatrin
44.7
11.0
13
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
10.8
50
154
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
29.0
10.8
14
5
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
22.2
10.8
15
7
TQW99
NOMESCO Finland
Other minor procedure on skin
5.4
10.8
32
64
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.0
10.7
43
117
N03AX14
ATC
levetiracetam; systemic
6.4
10.5
27
45
L81.3
ICD-10 Finland
Café au lait spots
113.1
10.5
11
*
ZXC12
NOMESCO Finland
Pulse colorlaser
113.1
10.5
11
*
Q85.88
ICD-10 Finland
Other phakomatoses, not elsewhere classified
+∞
10.5
10
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
16.6
10.4
16
10
N03AG01
ATC
valproic acid; systemic, rectal
4.1
10.4
41
110
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
7.8
10.3
23
31
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
10.5
10.1
19
19
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
41.3
10.0
12
*
G40.10
ICD-10 Finland
Simple partial seizures
20.7
9.9
14
7
XCK10
NOMESCO Finland
Photography of fundus of eye
3.5
9.8
47
149
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.1
9.8
23
34
ZXE00
NOMESCO Finland
One hour or less
2.0
9.4
159
998
QXA40
NOMESCO Finland
Skin laser treatment or photocoagulation, unspecified location
+∞
9.4
9
*
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
14.1
9.3
15
11
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.4
9.1
23
38
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
13.0
8.9
15
12
ZXA00
NOMESCO Finland
Right side
2.3
8.8
96
495
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.6
8.8
65
276
N03AF01
ATC
carbamazepine; oral, rectal
4.7
8.8
29
66
QBA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of trunk
51.2
8.7
10
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.5
8.7
18
22
N05BA09
ATC
clobazam; oral
10.4
8.6
16
16
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
92.1
8.4
9
*
QDA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of lower limb
92.1
8.4
9
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.8
8.4
17
20
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
+∞
8.4
8
*
Q85.81
ICD-10 Finland
Sturge-Weber syndrome
+∞
8.4
8
*
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
+∞
8.4
8
*
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
17.7
8.1
12
7
XCD10
NOMESCO Finland
Electrophysiological examination of eye
7.5
8.1
18
25
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
22.6
8.1
11
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
8.0
30
78
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
7.8
67
307
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
15.4
7.8
12
8
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
7.7
47
175
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
18.8
7.6
11
6
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.3
7.6
14
14
SPAT1229
SPAT
Assessment of need for aid
3.8
7.5
30
83
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
81.7
7.4
8
*
22550
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Peripheral nerves
81.7
7.4
8
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
7.1
7.4
17
25
R4120
NOMESCO Finland
Occupational therapy
3.2
7.3
38
129
7595A
ICD-9 Finland
Other and unspecified congenital anomalies, Tuberous sclerosis
+∞
7.3
7
*
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
7.3
7
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
7.3
7
*
QCA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of upper limb
+∞
7.3
7
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
16.1
7.3
11
7
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
30.7
7.2
9
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
30.7
7.2
9
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
7.0
45
175
N05BA01
ATC
diazepam; systemic, rectal
2.5
7.0
56
245
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.6
7.0
30
88
S18
ICPC
Laceration/cut
1.9
7.0
144
944
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
7.0
32
99
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
7.0
98
558
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
14.1
6.9
11
8
ZXA05
NOMESCO Finland
Left side
2.1
6.9
84
454
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.9
142
934
Z3226
NOMESCO Finland
Physiotherapist
2.1
6.8
81
429
H47.2
ICD-10 Finland
Optic atrophy
40.8
6.8
8
*
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
17.1
6.8
10
6
R4110
NOMESCO Finland
Physiotherapy
2.0
6.8
100
582
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
5.7
6.7
18
33
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.1
6.7
17
29
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
6.6
62
297
Z3229
NOMESCO Finland
Other healthcare associate professional
2.8
6.5
41
158
AA1AD
NOMESCO Finland
CT of head and brain
2.1
6.5
73
380
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
71.0
6.4
7
*
D31.2
ICD-10 Finland
Benign neoplasm: Retina
71.0
6.4
7
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
71.0
6.4
7
*
D48.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system
71.0
6.4
7
*
SPAT1153
SPAT
Removal of sutures
1.9
6.4
107
649
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.7
6.4
15
23
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.7
6.4
15
23
N03AX12
ATC
gabapentin; oral
2.3
6.3
57
267
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
18.4
6.3
9
5
N03AB02
ATC
phenytoin; systemic
18.4
6.3
9
5
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
18.4
6.3
9
5
340
Kela drug reimbursment
Everolimus
+∞
6.3
6
*
H52.2
ICD-10 Finland
Astigmatism
5.9
6.2
16
28
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.2
6.2
22
55
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
7.9
6.2
13
17
N03AX09
ATC
lamotrigine; oral
3.3
6.1
29
93
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
8.8
6.1
12
14
D18.0
ICD-10 Finland
Haemangioma, any site
5.7
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
39
33
12.93
39.07
4.7
3.4
nmol/l
2.1
7.5
0.58
39
33
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
40
39
11.23
36.55
3.7
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
36
10.52
30.73
3.4
1.4
nmol/l
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
225
1346
2.45
17.96
7.7
7.4
mmol/l
1.2
1.2
2.13
215
1235
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
79
282
3.22
17.52
6.4
10.5
kpa
5.0
5.2
0.64
73
270
(3003458) Phosphate [Moles/volume] in Serum or Plasma
100
409
2.90
17.48
6.8
8.2
mmol/l
1.0
1.1
1.12
94
387
(3003396) Base excess in Arterial blood by calculation
79
283
3.21
17.41
6.4
10.6
mmol/l
0.0
1.0
0.91
59
225
(3027801) Oxygen [Partial pressure] in Arterial blood
78
282
3.17
16.90
6.5
10.5
kpa
14.9
12.9
1.55
73
271
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
231
1465
2.28
15.27
9.1
7.8
mmol/l
1.2
1.2
1.42
201
1261
(4035726)
72
263
3.10
15.26
1.5
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
92
390
2.74
14.84
1.6
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
180
1065
2.21
13.69
6.2
6.6
inr
1.1
1.1
0.47
60
327
(40768804) Tissue Pathology biopsy report
203
1265
2.17
13.49
2.7
2.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
18
25
7.48
12.36
1.8
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
150
871
2.12
11.56
5.4
3.8
ph
7.4
7.4
0.14
36
152
(3000991) Gas panel - Venous blood
66
286
2.55
9.99
7.1
10.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
182
1205
1.90
9.21
6.3
5.4
g/l
35.9
36.8
1.21
169
1132
(3000850) Epithelial cells [#/volume] in Urine
112
629
2.06
9.13
2.3
2.6
e6/l
6.3
6.7
0.08
103
552
(3044640) Blood type and Crossmatch panel - Blood
158
1005
1.92
8.99
2.9
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
53
220
2.61
8.73
4.8
4.9
ng/l
111.7
69.5
0.82
46
202
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
10
10.22
8.67
2.1
2.2
umol/l
27.1
19.8
—
10
10
(3030467) Casts [#/volume] in Urine by Automated count
140
868
1.92
8.52
3.3
3.1
e6/l
1.1
0.4
0.51
121
632
(3009466) Valproate [Moles/volume] in Serum or Plasma
22
56
4.09
7.98
4.3
5.6
umol/l
422.0
366.1
0.76
22
51
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
139
2.91
7.94
5.8
14.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
21
52
4.20
7.89
1.9
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
148
955
1.85
7.84
3.3
3.2
e6/l
25.7
109.1
0.63
132
717
(3007853) Bacteria identified in Skin by Aerobe culture
73
368
2.19
7.78
2.5
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
241
1814
1.77
7.49
6.4
5.1
mmol/l
6.2
6.5
2.80
236
1675
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
207
1496
1.76
7.38
4.6
4.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
135
867
1.82
7.15
3.3
3.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
66
332
2.17
7.05
10.5
7.2
mmol/l
105.4
104.1
1.25
66
324
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
162
1110
1.75
6.83
3.6
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
25
78
3.34
6.81
1.8
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
39
158
2.62
6.74
4.0
7.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
165
1149
1.72
6.49
4.2
3.6
e6/l
22.7
43.7
1.44
140
768
(3002032) Base excess in Venous blood by calculation
61
308
2.15
6.44
4.5
6.3
mmol/l
1.2
1.7
0.54
46
243
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
212
1598
1.66
6.07
6.7
6.4
umol/l
10.3
12.5
2.09
196
1515
(3012544) pH of Venous blood
61
317
2.08
5.97
4.5
6.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
112
714
1.78
5.94
5.3
4.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
57
294
2.09
5.69
2.8
2.8
g/l
0.2
0.2
0.70
51
275
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
88
529
1.84
5.64
2.9
2.7
e6/l
1.0
0.8
0.14
57
289
(3042936) Bacteria identified in Isolate by Culture
73
416
1.91
5.51
3.5
2.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
291
2431
1.64
5.12
8.2
6.9
u/l
80.0
79.9
0.02
275
2285
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
46
230
2.12
4.98
2.7
2.5
ml/min/173m2
79.0
73.0
0.43
21
96
(3026782) Osmolality of Urine
95
608
1.73
4.88
2.6
2.7
mosm/kgh2o
611.2
556.7
1.14
89
520
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
504
1.78
4.85
3.0
2.9
e6/l
3.6
2.4
0.53
52
266
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
63
3.11
4.73
4.4
3.7
%
55.4
56.8
0.18
19
63
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
113
769
1.64
4.59
2.7
2.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
51
274
1.98
4.56
4.1
3.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
18
60
3.09
4.45
4.8
3.5
mmol/l
2.0
2.8
—
9
36
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
132
947
1.57
4.27
2.7
2.6
u/l
49.7
57.3
2.51
119
885
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
62
2.99
4.22
2.0
3.4
e9/l
3.3
4.4
1.49
18
62
(3021901) Oxygen saturation in Capillary blood
14
41
3.50
4.22
2.7
7.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
134
968
1.56
4.20
3.4
3.2
mmol/l
2.4
2.4
0.05
123
858
(3029937) Albumin [Presence] in Urine by Test strip
116
824
1.56
3.87
3.7
3.6
estimate
0.0
0.0
0.80
40
300
(3044889) 12 lead EKG panel
257
2160
1.49
3.78
3.9
3.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
72
457
1.69
3.77
3.3
2.5
umol/l
13.1
14.1
0.53
67
426
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
190
2.04
3.76
1.8
1.6
—
—
—
0
0
(3020891) Body temperature
24
104
2.39
3.66
6.4
4.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
41
3.24
3.52
1.8
1.7
—
—
—
0
0
(3010421) pH of Blood
18
69
2.68
3.52
4.9
3.3
ph
7.4
7.4
0.26
18
59
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
168
1313
1.47
3.50
2.7
2.5
nmol/l
72.6
74.8
0.53
158
1202
(1616796) Gas panel - Central venous blood
15
53
2.90
3.39
5.5
4.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
77
2.54
3.34
1.5
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
165
2.02
3.24
1.3
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
49
2.92
3.22
2.9
3.3
%
16.7
16.3
—
8
24
(3019550) Sodium [Moles/volume] in Serum or Plasma
370
3414
1.70
3.16
20.9
13.2
mmol/l
139.3
139.7
2.23
361
3324
(40768797) Stomach Pathology biopsy report
63
409
1.64
3.03
1.7
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
43
252
1.79
2.99
2.5
4.3
ug/l
8.9
7.1
0.13
32
204
(3000494) Fungus identified in Specimen by Culture
58
371
1.65
2.96
1.7
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
35
3.20
2.95
1.5
3.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
22
4.16
2.89
2.3
2.2
ug/l
13.5
20.2
—
9
22
(3035350) Ketones [Presence] in Urine by Test strip
196
1619
1.39
2.86
3.5
3.2
estimate
0.0
0.0
0.00
37
299
(3009343) pH of Capillary blood
42
248
1.77
2.85
3.7
7.1
ph
7.4
7.4
—
6
18
(3011397) Hemoglobin [Presence] in Urine by Test strip
101
742
1.48
2.80
3.9
3.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
369
3424
1.64
2.80
21.0
13.3
mmol/l
4.0
3.9
0.21
360
3324
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
133
1030
1.43
2.80
3.3
3.2
ng/l
20.4
30.5
1.08
81
609
(3021601) Nitrite [Presence] in Urine by Test strip
196
1624
1.39
2.78
4.7
4.5
estimate
0.0
0.0
0.50
42
308
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
49
305
1.69
2.77
1.6
1.8
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
6
8.41
2.75
2.4
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
60
395
1.61
2.74
3.7
2.5
%
25.4
24.0
0.26
50
350
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
41
245
1.75
2.68
3.7
7.1
mmol/l
1.8
1.4
0.45
28
180
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
141
1114
1.40
2.62
3.9
3.5
u/l
36.7
32.3
0.19
134
1065
(3008898) HLA-B27 [Presence]
7
194
0.35
2.61
1.0
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
63
425
1.57
2.60
3.5
2.5
g/l
2.2
2.4
1.97
57
400
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
98
727
1.45
2.58
1.9
2.3
mg/l
1.1
1.0
0.16
75
548
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
108
2.09
2.56
1.8
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
196
1645
1.36
2.49
3.5
3.3
estimate
0.0
0.0
0.00
43
288
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
275
0.42
2.40
1.5
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
256
2246
1.36
2.40
4.4
4.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
8
22
3.69
2.37
2.0
1.3
umol/l
2.5
6.4
—
8
22
(3052851) Hemolysis interference index of Serum or Plasma
19
91
2.14
2.36
3.0
2.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
77
557
1.47
2.30
3.3
3.6
ng/l
267.1
358.2
0.14
49
378
(42870588) Differential panel, method unspecified - Blood
142
1146
1.36
2.27
7.5
6.9
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
7
18
3.94
2.26
4.1
2.4
nmol/l
0.1
0.1
—
7
13
(40758558) Short blood count panel - Blood
113
880
1.39
2.25
5.7
7.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
230
1999
1.33
2.23
9.6
9.5
e9/l
4.4
4.0
1.53
200
1741
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
62
432
1.51
2.22
1.7
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
379
0.53
2.17
2.0
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
20
3.54
2.06
1.1
3.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
185
1572
1.32
2.05
10.8
9.2
e9/l
0.0
0.0
0.84
151
1275
(4198724)
8
26
3.12
2.02
1.0
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
57
2.32
1.99
1.8
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
77
2.12
1.99
1.3
1.2
—
—
—
0
0
(3015736) pH of Urine
153
1273
1.32
1.95
3.6
3.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
103
1285
0.74
1.95
2.7
2.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
45
2.48
1.94
1.2
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
45
2.48
1.94
1.6
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
16
3.79
1.94
1.8
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
46
310
1.54
1.93
1.6
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
106
840
1.35
1.87
2.8
2.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
41
273
1.56
1.82
3.4
3.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
184
1584
1.29
1.78
6.3
6.7
%
0.7
0.7
0.05
173
1488
(3044290) Cell count panel - Cerebral spinal fluid
15
74
2.07
1.77
1.4
2.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
24
140
1.76
1.76
2.2
2.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
38
553
0.66
1.71
1.3
1.3
u/ml
1.1
9.0
3.40
14
223
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
94
742
1.34
1.70
2.6
2.2
mg/l
3.2
3.0
0.30
83
628
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
55
2.22
1.69
4.0
3.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
12
55
2.22
1.69
6.7
6.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
189
1642
1.27
1.68
7.0
6.9
%
9.0
8.4
1.43
179
1552
(3030981) Hyaline casts [#/volume] in Urine by Automated count
25
150
1.71
1.67
2.0
2.9
e6/l
1.0
0.1
0.64
25
144
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
72
548
1.38
1.64
1.8
1.6
pmol/l
412.7
447.8
0.72
56
467
(3002030) Lymphocytes/100 leukocytes in Blood
194
1696
1.27
1.62
6.5
6.7
%
27.5
29.9
1.39
183
1602
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
327
3050
1.33
1.61
16.2
10.3
ml/min/173m2
92.7
89.6
1.29
282
2449
(40765089) Chromosome analysis panel - Blood by G-banded
7
26
2.72
1.58
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
33
2.45
1.54
1.8
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
44
2.30
1.54
1.8
3.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
203
1794
1.25
1.52
6.2
6.9
e9/l
0.2
0.2
0.27
175
1588
(3006504) Eosinophils/100 leukocytes in Blood
186
1630
1.25
1.49
6.6
6.7
%
2.7
2.9
0.33
176
1529
(3007164) IgA [Mass/volume] in Serum or Plasma
68
870
0.74
1.48
1.4
1.4
g/l
2.1
2.2
0.03
47
510
(3009214) Lutropin [Units/volume] in Serum or Plasma
25
156
1.64
1.47
2.4
1.7
u/l
7.2
7.7
0.09
19
120
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
38
2.40
1.46
1.8
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
50
670
0.71
1.46
2.2
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
146
1247
1.26
1.45
3.5
3.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
58
435
1.39
1.45
1.9
1.6
nmol/l
1086.9
1200.0
0.44
41
332
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
380
3643
1.45
1.45
11.3
9.3
u/l
23.7
27.6
4.39
366
3537
(3012565) Volume of 24 hour Urine
5
16
3.15
1.44
1.4
2.1
ml
1686.0
2109.1
—
5
16
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
22
2.75
1.44
1.0
1.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
196
1737
1.24
1.40
6.1
6.4
e9/l
0.0
0.0
0.65
167
1509
(21494434) Karyotype in Bone marrow
7
29
2.44
1.40
1.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
33
224
1.51
1.38
2.2
1.6
iu/l
5.8
21.0
11.20
24
185
(21494890) Protein electrophoresis panel - 24 hour Urine
6
23
2.63
1.37
1.0
2.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
618
0.71
1.37
2.0
2.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
17
2.96
1.36
1.6
2.9
umol/l
22.0
26.6
—
5
17
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
5
17
2.96
1.36
1.2
1.1
u/l
51.4
41.0
—
5
12
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
5
17
2.96
1.36
1.2
1.1
u/l
152.4
114.2
—
5
12
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
16
90
1.81
1.35
1.2
2.5
mg/l
480.0
416.0
0.43
16
85
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
42
2.17
1.34
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
45
329
1.41
1.31
9.1
6.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
2.2
1.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
55
2.03
1.28
2.2
1.4
ug/l
2.2
3.4
0.88
11
49
(3050129) First trimester maternal screen panel - Serum or Plasma
8
158
0.50
1.27
1.1
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
255
2753
0.81
1.27
3.2
3.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
77
1.85
1.27
1.2
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
194
1732
1.22
1.25
6.1
6.4
e9/l
0.6
0.6
2.54
166
1504
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
6
25
2.42
1.25
1.0
1.1
mg/l
28.6
31.7
—
6
20
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
78
1.82
1.22
1.9
2.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
37
2.18
1.22
1.3
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
37
2.18
1.22
2.0
3.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
2.2
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
19
2.65
1.22
2.0
3.7
ug/l
0.4
1.9
—
5
19
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
2.2
1.6
—
—
—
0
0
(4281824)
6
26
2.33
1.19
2.7
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
30
207
1.48
1.19
3.8
7.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
79
1.80
1.18
1.4
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
77
623
1.29
1.18
1.7
1.4
nmol/l
18.0
21.6
1.87
68
541
(3019198) Lymphocytes [#/volume] in Blood
199
1791
1.21
1.16
6.1
6.4
e9/l
1.9
2.0
0.83
172
1586
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
233
0.59
1.15
1.6
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
20
2.52
1.15
9.6
2.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
20
2.52
1.15
1.6
1.2
umol/l
26.5
16.7
—
5
20
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
58
453
1.33
1.15
3.0
2.6
mmol/l
2.5
2.4
0.37
53
398
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
14
80
1.78
1.14
1.1
2.5
mmol/l
3.8
3.6
0.18
14
75
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
121
0.49
1.07
1.2
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
124
1074
1.22
1.05
2.0
1.8
pmol/l
96.1
97.6
0.12
72
551
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
238
0.62
1.04
1.1
1.0
—
—
—
0
0
(4027681)
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
34
2.08
1.03
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
7
35
2.02
1.00
3.6
3.1
—
19.4
—
0
7
(3017181) Myelocytes/100 leukocytes in Blood
35
259
1.38
0.99
3.3
4.4
%
1.0
0.8
—
8
74
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
378
3660
1.33
0.96
17.3
10.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
25
177
1.44
0.90
1.6
2.3
u/l
321.1
3079.6
—
7
71
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
101
0.49
0.90
1.2
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
184
1676
1.17
0.88
6.3
6.5
%
58.0
55.4
1.54
172
1587
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
361
3484
1.26
0.87
17.5
11.8
mg/l
24.9
21.6
1.00
298
2628
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
311
1.32
0.85
1.7
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
57
1.77
0.84
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
65
1.71
0.83
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
65
1.71
0.83
1.1
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
84
717
1.21
0.83
4.0
3.4
kg/l
1.0
1.0
0.72
13
101
(3023520) Reticulocytes [#/volume] in Blood
31
233
1.36
0.82
3.0
3.5
e9/l
59.3
70.7
1.61
19
174
(3007461) Platelets [#/volume] in Blood
403
3953
1.48
0.82
26.0
17.3
e9/l
261.7
256.1
0.89
392
3857
(21494755) Public health laboratory ask at order entry panel
37
471
0.76
0.81
1.2
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
33
1.83
0.79
1.0
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
121
0.57
0.79
1.1
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
121
0.57
0.79
1.1
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
121
0.57
0.79
1.1
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
99
0.50
0.78
1.0
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
403
3956
1.46
0.78
25.9
17.2
fl
89.1
89.9
2.85
398
3907
(3035941) MCH [Entitic mass]
403
3956
1.46
0.78
25.9
17.2
pg
29.8
30.1
2.44
398
3906
(4146454)
0
27
0.00
0.77
0.0
2.6
—
—
—
0
0
(3013512) EKG study
90
779
1.20
0.77
2.9
3.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
42
522
0.78
0.77
1.8
2.6
ug/g
65.8
102.7
1.10
33
416
(3026361) Erythrocytes [#/volume] in Blood
403
3957
1.46
0.76
26.0
17.2
e12/l
4.6
4.6
0.02
392
3852
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
91
1.56
0.76
1.6
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
141
1.44
0.76
1.5
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
85
734
1.20
0.75
2.9
3.0
umol/l
333.1
4841.8
2.37
75
654
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.74
1.8
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
24
2.10
0.74
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
55
1.65
0.74
1.6
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
50
409
1.25
0.74
2.7
3.4
umol/l
5.8
7.8
0.81
42
353
(3010813) Leukocytes [#/volume] in Blood
403
3959
1.44
0.73
26.1
17.3
e9/l
7.1
6.7
1.50
391
3855
(3000963) Hemoglobin [Mass/volume] in Blood
403
3959
1.44
0.73
26.2
17.4
g/l
135.4
137.2
1.47
398
3907
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
39
1.81
0.73
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
99
870
1.18
0.72
1.6
1.7
mmol/l
1.3
1.4
0.32
93
752
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
46
560
0.80
0.71
1.3
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
348
3365
1.20
0.70
18.6
12.9
%
40.5
40.7
0.26
260
2696
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
373
0.76
0.70
1.8
1.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
12
77
1.57
0.69
8.3
3.6
mmol/l
3.7
3.9
1.22
12
69
(40760888) Immunoglobulin light chains.free panel - Serum
7
42
1.68
0.68
2.1
5.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
578
0.81
0.68
1.3
1.3
iu/ml
14.0
34.9
3.29
16
183
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
28
1.79
0.66
1.6
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
178
0.66
0.66
2.7
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
29
1.73
0.64
4.8
3.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
87
1.51
0.64
2.2
2.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
276
2631
1.14
0.63
4.8
3.8
pmol/l
14.8
14.6
0.99
256
2419
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.9
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
165
1523
1.14
0.62
3.6
2.8
ug/l
107.4
95.3
0.35
153
1426
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.4
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.4
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
8
50
1.61
0.61
1.5
2.9
u/ml
12.3
34.8
—
8
50
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
80
1.51
0.60
2.3
2.1
g/l
6.9
7.2
—
6
66
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
80
1.51
0.60
2.3
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
84
948
0.86
0.60
1.4
1.4
u/ml
1.3
2.1
0.38
18
236
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
255
2426
1.13
0.58
3.7
3.9
mm/h
11.5
9.7
1.14
237
2250
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
323
3121
1.15
0.57
4.0
3.9
mmol/l
5.6
5.8
2.49
296
2894
(3017143) Hepatitis C virus Ab [Presence] in Serum
59
507
1.19
0.57
2.0
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
89
0.56
0.56
2.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
55
1.46
0.56
1.5
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
90
1.46
0.56
1.7
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
249
2369
1.13
0.56
3.3
3.1
u/l
40.1
42.7
0.28
238
2253
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
125
0.63
0.55
1.6
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
99
1.43
0.55
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
38
1.59
0.54
2.0
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
241
1.26
0.54
3.5
4.6
%
0.2
0.2
—
5
64
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
74
1.50
0.54
2.4
2.2
g/l
2.6
3.1
—
6
63
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
301
2900
1.13
0.53
4.7
4.9
mmol/mol
37.2
38.8
2.43
278
2738
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
16
117
1.38
0.53
1.4
2.4
g/l
1.3
1.4
0.20
16
103
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
99
0.60
0.52
1.0
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
102
927
1.13
0.48
2.8
2.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
102
1.39
0.48
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
146
1.32
0.48
1.9
2.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
41
481
0.84
0.47
1.4
1.4
titre
430.0
455.0
—
8
101
(3045424) Erythrocytes [Presence] in Urine
7
48
1.47
0.47
1.1
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
118
0.67
0.46
1.5
2.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
138
1.32
0.46
1.3
1.3
—
—
—
0
0
(44790048)
7
49
1.44
0.46
1.6
1.9
—
—
—
0
0
(44790047)
7
49
1.44
0.46
1.6
1.9
—
—
—
0
0
(44806118)
7
49
1.44
0.46
1.6
1.9
—
—
—
0
0
(44790049)
7
49
1.44
0.46
1.6
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
303
3123
0.89
0.45
3.9
3.6
mmol/l
1.2
1.3
0.87
276
2928
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.3
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
50
1.41
0.45
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.8
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
33
277
1.21
0.42
1.7
3.0
g/l
10.2
9.9
0.13
33
253
(4094501)
11
79
1.40
0.41
1.2
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
28
232
1.22
0.41
3.9
4.6
%
0.8
0.2
—
5
58
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
223
1.23
0.41
1.4
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
17
0.00
0.40
0.0
5.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
345
0.83
0.40
3.6
4.1
%
32.9
31.6
0.27
22
238
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
97
1.35
0.40
1.2
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
35
1.43
0.39
5.4
2.8
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
80
1.39
0.39
2.4
2.1
g/l
3.5
3.7
—
6
63
(3023183) Ammonium ion [Moles/volume] in Plasma
9
67
1.35
0.38
1.7
4.6
umol/l
35.3
37.5
—
9
57
(3016879) Cocaine [Presence] in Urine
20
246
0.80
0.38
1.8
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
8
114
0.70
0.37
1.6
1.8
—
253.3
—
0
6
(3023419) Bacteria identified in Sputum by Culture
5
37
1.36
0.37
3.2
2.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
72
1.40
0.37
1.6
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
87
798
1.11
0.36
4.2
4.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
35
301
1.18
0.36
4.0
5.2
u/l
234.0
252.2
0.43
35
291
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
71
1.27
0.36
1.7
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
76
0.65
0.36
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
316
3235
0.91
0.35
4.2
3.9
mmol/l
1.4
1.5
0.09
291
3039
(3028300) Cannabinoids [Presence] in Urine
22
265
0.82
0.35
2.1
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.3
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
43
1.40
0.35
1.3
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
264
0.82
0.34
2.0
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
263
0.83
0.33
2.2
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
47
1.28
0.32
1.8
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
22
262
0.83
0.32
2.1
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
119
1.27
0.32
1.4
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
15
186
0.80
0.31
2.4
1.9
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
99
0.70
0.31
1.1
1.3
—
2.5
—
0
5
(3025941) Bacteria identified in Stool by Culture
21
175
1.21
0.30
1.6
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
82
884
0.91
0.30
2.2
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
130
0.76
0.30
3.3
3.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
63
1.28
0.28
1.5
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
64
1.25
0.27
1.3
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
12
150
0.79
0.27
1.2
1.4
miu/ml
168.4
267.5
—
5
73
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
15
122
1.24
0.27
1.0
1.1
—
12.7
—
0
16
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
65
1.24
0.27
2.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
113
1.25
0.27
1.8
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
71
0.70
0.26
1.2
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
73
0.68
0.26
1.2
1.2
—
1.1
—
0
5
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
75
0.66
0.26
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
127
0.78
0.26
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
38
341
1.13
0.24
1.4
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
11
88
1.26
0.22
2.2
1.6
iu/l
2.6
5.5
—
6
27
(3003327) Ova and parasites identified in Stool by Light microscopy
12
146
0.82
0.22
1.7
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
41
1.22
0.22
1.0
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
41
1.22
0.22
11.8
3.8
%
1.0
1.0
—
5
34
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
9.9
—
0
11
(3006462) Nitrate [Presence] in Urine
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
6.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
10
0.00
0.21
0.0
2.2
—
4.1
—
0
10
(3025577) Chromium [Mass/volume] in Blood
0
10
0.00
0.21
0.0
2.2
—
2.4
—
0
10
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
46
500
0.91
0.21
1.5
1.7
—
—
—
0
0
(4211845)
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(4010399)
25
221
1.14
0.20
1.5
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
323
3277
0.94
0.19
4.7
4.3
mmol/l
2.8
2.8
0.21
296
3070
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
320
3247
0.94
0.19
4.3
3.9
mmol/l
4.7
4.7
0.24
294
3066
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
373
0.90
0.19
2.2
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
105
1004
1.06
0.18
1.4
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
58
1.21
0.18
1.3
1.2
—
—
—
0
0
(4306422)
7
59
1.19
0.18
1.6
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
67
0.74
0.17
1.8
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
80
0.75
0.15
1.7
2.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
88
0.79
0.14
1.4
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
122
1.15
0.14
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
98
0.81
0.14
2.3
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
100
0.80
0.13
2.5
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
273
0.91
0.13
2.0
1.3
iu/ml
115.3
161.4
0.40
14
116
(3009445) Proteinase 3 Ab [Units/volume] in Serum
16
142
1.13
0.13
1.3
1.5
—
10.1
—
0
5
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
41
436
0.93
0.12
2.5
2.7
ug/l
0.7
0.7
0.02
28
262
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
85
1.18
0.12
1.3
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
105
1.15
0.11
1.5
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
77
742
1.05
0.11
4.4
4.3
ug/l
2.2
1.8
0.59
72
665
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
67
697
0.95
0.10
1.9
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
208
0.91
0.10
1.7
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
361
0.94
0.10
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
87
898
0.96
0.10
1.6
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.0
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
62
596
1.05
0.09
4.1
3.9
%
23.4
22.3
0.22
29
250
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
114
0.87
0.09
1.2
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
97
1.14
0.09
1.1
1.8
u/ml
217.0
205.5
—
5
58
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
58
1.03
0.08
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
55
571
0.96
0.08
1.5
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
94
964
0.97
0.08
3.1
3.2
mmol/l
8.1
8.1
0.04
89
838
(1761482) Bacteria [#/volume] in Urine by Culture
6
71
0.84
0.07
2.7
3.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
70
0.86
0.07
2.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
79
768
1.04
0.07
3.3
3.2
mg/l
1762.7
78.6
0.99
63
501
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
13
143
0.91
0.07
1.4
2.1
u/l
35.7
40.5
0.41
13
130
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
78
1.03
0.07
4.1
9.1
—
387.4
—
0
16
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
316
3137
1.03
0.07
5.3
4.4
mu/l
1.9
1.9
0.10
294
2928
(3001019) Free T4 and TSH panel - Serum or Plasma
20
214
0.93
0.07
1.5
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
87
1.04
0.07
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
27
256
1.06
0.06
5.8
4.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
13
119
1.10
0.06
1.5
1.5
g/l
0.2
0.2
0.42
13
113
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
181
0.94
0.05
1.1
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
120
0.91
0.05
1.5
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
53
516
1.03
0.04
2.5
1.8
%
1.3
1.4
0.97
46
461
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
101
1.09
0.04
1.1
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
109
0.92
0.04
1.8
1.2
—
—
—
0
0
(4034850)
12
111
1.08
0.04
8.1
10.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
79
803
0.98
0.03
4.0
4.0
mg/mmol
4.5
11.6
2.62
63
516
(3045414) Leukocytes [Presence] in Urine
13
122
1.07
0.02
1.1
1.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
13
123
1.06
0.01
1.5
1.5
g/l
1.0
1.2
1.82
13
115
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
116
0.95
0.00
1.2
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
24
234
1.03
0.00
3.6
3.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
31
304
1.02
0.00
2.0
1.9
—
—
—
0
0
(3000492) Spirometry study
36
366
0.98
0.00
1.4
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
103
0.97
0.00
2.0
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
201
0.99
0.00
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
153
0.98
0.00
2.2
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
22
225
0.98
0.00
1.6
1.7
g/l
3.0
1.2
0.44
22
208
(1002224) Polysomnography panel
16
164
0.97
0.00
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
186
1.02
0.00
2.4
2.1
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
6
0.00
0.00
0.0
2.7
—
109.7
—
0
6
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
54
0.93
0.00
1.4
1.0
g/l
1.6
1.3
—
5
49
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
63
0.95
0.00
1.0
1.8
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
12.8
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
57.5
—
0
8
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3000475) Leukocytes [#/volume] in Synovial fluid
6
63
0.95
0.00
1.8
1.4
e6/l
1968.7
8899.0
—
6
48
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
259.2
—
0
5
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
6.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
68.7
—
0
9
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
8.1
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
49
1.02
0.00
2.0
2.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
8.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
6.3
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
99
0.91
0.00
1.4
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
59
1.02
0.00
1.8
1.6
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
66
0.91
0.00
2.7
7.7
—
2749.8
—
0
10
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
20.4
—
0.5
—
0
7
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED | 2.597 [2.1, 3.21] | < 0.001 |
| Birth year | 0.996 [0.99, 1.01] | 0.496 |
During the follow-up period (1.1.1998 — 31.12.2019), 166 out of 1530 females with Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED | 2.467 [1.98, 3.07] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 195 out of 1477 males with Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED died.
Mortality risk
Mortality risk for people of age
years, who have Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.235% | 0.449% |
| 5 | 1.518% | 2.752% |
| 10 | 3.83% | 7.147% |
| 15 | 7.45% | 12.817% |
| 20 | 13.17% | 20.695% |
Relationships between endpoints
↥Index endpoint: Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED – Phakomatoses, not elsewhere classified
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data